PGC-1α/β induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders

Department of Neurology, University of Miami School of Medicine, Miami, FL 33136, USA.
Human Molecular Genetics (Impact Factor: 6.68). 04/2009; 18(10):1805-12. DOI: 10.1093/hmg/ddp093
Source: PubMed

ABSTRACT Members of the peroxisome proliferator-activated receptor gamma coactivator (PGC) family are potent inducers of mitochondrial biogenesis. We have tested the potential effect of increased mitochondrial biogenesis in cells derived from patients harboring oxidative phosphorylation defects due to either nuclear or mitochondrial DNA mutations. We found that the PGC-1alpha and/or PGC-1beta expression improved mitochondrial respiration in cells harboring a complex III or IV deficiency as well as in transmitochondrial cybrids harboring mitochondrial encephalomyopathy lactic acidosis and stroke A3243G tRNA((Leu)UUR) gene mutation. The respiratory function improvement was found to be associated with increased levels of mitochondrial components per cell, although this increase was not homogeneous. These results reinforce the concept that increased mitochondrial biogenesis is a promising venue for the treatment of mitochondrial diseases.

Download full-text


Available from: Francisca Diaz, Aug 09, 2015
1 Follower
  • Source
    • "Studies in mouse models of mitochondrial diseases indicate that overexpression of PGC-1α alleviates mitochondrial defects and triggers mitochondrial proliferation (Viscomi et al., 2011). Additionally, studies in human cells with complex III or IV deficiency showed that expression of PGC- 1α, and/or its homologue PGC-1β, improves mitochondrial respiration (Srivastava et al., 2009). Therefore, PGC-1α is characterized as the master regulator of mitochondrial biogenesis and function. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondria are highly dynamic organelles and their proper function is crucial for the maintenance of cellular homeostasis. Mitochondrial biogenesis and mitophagy are two pathways that regulate mitochondrial content and metabolism preserving homeostasis. The tight regulation between these opposing processes is essential for cellular adaptation in response to cellular metabolic state, stress and other intracellular or environmental signals. Interestingly, imbalance between mitochondrial proliferation and degradation process results in progressive development of numerous pathologic conditions. Here we review recent studies that highlight the intricate interplay between mitochondrial biogenesis and mitophagy, mainly focusing on the molecular mechanisms that govern the coordination of these processes and their involvement in age-related pathologies and ageing.
    Experimental gerontology 08/2014; 56. DOI:10.1016/j.exger.2014.01.021 · 3.53 Impact Factor
  • Source
    • "These observations have suggested the hypothesis that the deleterious effects of either mtDNA-or nuclear-gene mutations could be overcome, at least partially, by increasing the total amount of mitochondria and/or of functionally active " MRC units, " via activation of the mitochondrial biogenesis program in critical tissues (Bastin et al., 2008; Wenz et al., 2008). This idea has first been tested in cells from mitochondrial disease patients, by overexpressing recombinant PGC-1α or by adding bezafibrate in the medium (Bastin et al., 2008; Srivastava et al., 2009). Both treatments showed mutant cells to partially recover MRC activities and increase ATP production. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Increased mitochondrial biogenesis by activation of PPAR- or AMPK/PGC-1α-dependent homeostatic pathways has been proposed as a treatment for mitochondrial disease. We tested this hypothesis on three recombinant mouse models characterized by defective cytochrome c-oxidase (COX) activity: a knockout (KO) mouse for Surf1, a knockout/knockin mouse for Sco2, and a muscle-restricted KO mouse for Cox15. First, we demonstrated that double-recombinant animals overexpressing PGC-1α in skeletal muscle on a Surf1 KO background showed robust induction of mitochondrial biogenesis and increase of mitochondrial respiratory chain activities, including COX. No such effect was obtained by treating both Surf1(-/-) and Cox15(-/-) mice with the pan-PPAR agonist bezafibrate, which instead showed adverse effects in either model. Contrariwise, treatment with the AMPK agonist AICAR led to partial correction of COX deficiency in all three models, and, importantly, significant motor improvement up to normal in the Sco2(KO/KI) mouse. These results open new perspectives for therapy of mitochondrial disease.
    Cell metabolism 07/2011; 14(1):80-90. DOI:10.1016/j.cmet.2011.04.011 · 16.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Numerical simulation of steady-state thermal behaviour of ball grid array (BGA) electronic packages can be greatly eased through the simplification of small-scale geometric features. Such features include plated through-holes (PTHs), vias, controlled collapse chip connection (C4) solder joints, extended evaporated eutectic (E3) solder joints, controlled collapse chip connection carrier (C5) solder joints, and printed wiring board (PWB) copper trace patterns. Accurate and timely system-level modeling relies on simplifying the geometric representation of these features while capturing their thermal effects. A strict, single-pass modeling methodology based solely on design data and readily available bulk material properties is presented
    Thermal and Thermomechanical Phenomena in Electronic Systems, 1998. ITHERM '98. The Sixth Intersociety Conference on; 06/1998
Show more